OPTIMISING ORGAN VIABILITY AND UTILISATION
Despite over 70 years of developments in human organ transplant, today around 70-80% of all donated organs world wide are still transported and preserved by static cold storage (SCS), i.e. on ice, in a box that closely resembles (or indeed is) a picnic cool-box.
EVERY DONOR ORGAN DESERVES THE BEST PRESERVATION
“We’re unlocking one of the most underserved and economically inefficient spaces in modern medicine: organ transplantation.
While procedures like kidney and heart transplants cost over $1 million and face critical bottlenecks - from donor matching to immunologic rejection - our solution will deliver a step-change in both patient outcomes and system-level savings.
With over $100B in global transplant spend annually and accelerating demand from aging populations and chronic disease, we’re not just aiming to improve care - we’re redefining the economics of survival.
Our commercial strategy will target early adoption through top OPOs and transplant centers, scales via integrated partnerships, and captures value across clinical, regulatory, and data-driven channels.
We’re built to scale, and the system can’t afford to wait.”
— David Campbell, CEO ScubaTx
Our approach
Leveraging 20+ years of R&D from the research labs of our founding scientist Dr William (Bill) Scott, ScubaTx have developed a breakthrough organ-preservation platform leveraging proprietary advanced temperature control (ATC) with and without Persufflation (gaseous oxygen-perfusion, PSF).
Our approach represents a simple, portable, and fully automated ‘plug-and-play’ multi-organ system, capable of achieving 24hrs tuneable/accurate hypothermic-temperatures with and without PSF.
The platform is design to meet the needs of clinical teams in highly cost-constrained healthcare systems enabling widespread deployment and improving utilisation of donor-organs.